2024
Personalized risk assessment of new onset depression in long-term cancer survivors.
Taylor M, Westvold S, Long J, Hyslop T, Wang S, Cecchini M, Leapman M, Leeds I, Lustberg M, Spees L, Wheeler S, Gross C, Oeffinger K, Dinan M. Personalized risk assessment of new onset depression in long-term cancer survivors. Journal Of Clinical Oncology 2024, 42: e13798-e13798. DOI: 10.1200/jco.2024.42.16_suppl.e13798.Peer-Reviewed Original ResearchHistory of depressionIncidence of depressionCumulative incidence of depressionRisk of developing depressionLong-term survivorsPredictors of depressionCancer survivorsDisease specific factorsCumulative incidenceNon-HispanicHigher risk of developing depressionRectal cancerLong-term cancer survivorsBreast cancer survivorsCensus tract povertyColon cancerEpisodes of bipolar I disorderPrevalence of depressionMean survival time modelsDiagnosis of depressionReceipt of treatmentAssociated with prior historyHormone receptor statusPatients aged <Adjuvant endocrine therapy
2022
Treatment exposure-based risk-stratification for care of survivors of childhood cancer: A report from the Childhood Cancer Survivor Study.
Dinan M, Stratton K, Leisenring W, Yasui Y, Chow E, Moskowitz C, Yeh J, Noyd D, Armstrong G, Oeffinger K. Treatment exposure-based risk-stratification for care of survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Journal Of Clinical Oncology 2022, 40: 10056-10056. DOI: 10.1200/jco.2022.40.16_suppl.10056.Peer-Reviewed Original ResearchChildhood Cancer Survivor StudyHigh-risk groupHigh-risk survivorsCancer Survivor StudyRisk groupsGrade 3Hazard ratioRisk survivorsAge 20Cumulative incidenceChronic conditionsSurvivor StudyChildhood cancerAge 35Treatment exposureLow-risk survivorsFive-year survivorsHigh-risk patientsRisk stratification algorithmConfidence intervalsProportional hazards modelLong-term surveillanceCare of survivorsLate mortalityPrimary endpoint
2020
Prevalence, screening, treatment, and complications of osteoporosis and osteopenia in Medicare patients with chronic lymphocytic leukemia (CLL).
Brander D, Oeffinger K, Greiner M, Dinan M. Prevalence, screening, treatment, and complications of osteoporosis and osteopenia in Medicare patients with chronic lymphocytic leukemia (CLL). Journal Of Clinical Oncology 2020, 38: e24050-e24050. DOI: 10.1200/jco.2020.38.15_suppl.e24050.Peer-Reviewed Original ResearchDual-energy X-ray absorptiometryChronic lymphocytic leukemiaFragility fracturesCumulative incidenceBone mineral density screeningComplications of osteoporosisUse of bisphosphonatesRoutine health maintenanceX-ray absorptiometryWilcoxon rank sum testChi-square testRank sum testCumulative incidence functionBisphosphonate useBaseline characteristicsMedicare 5Adverse outcomesBMD screeningTreatment advancesGray's testChronic cancerMedicare patientsDXA useLymphocytic leukemiaHigh risk